APA (7th ed.) Citation

Kang, Y., Hong, E. K., Rhim, J. H., Yoo, R., Kang, K. M., Yun, T. J., . . . Choi, S. H. (2020). Prognostic Value of Dynamic Contrast-Enhanced MRI-Derived Pharmacokinetic Variables in Glioblastoma Patients: Analysis of Contrast-Enhancing Lesions and Non-Enhancing T2 High-Signal Intensity Lesions. Korean journal of radiology, 21(6), 707-716. https://doi.org/10.3348/kjr.2019.0629

Chicago Style (17th ed.) Citation

Kang, Yeonah, et al. "Prognostic Value of Dynamic Contrast-Enhanced MRI-Derived Pharmacokinetic Variables in Glioblastoma Patients: Analysis of Contrast-Enhancing Lesions and Non-Enhancing T2 High-Signal Intensity Lesions." Korean Journal of Radiology 21, no. 6 (2020): 707-716. https://doi.org/10.3348/kjr.2019.0629.

MLA (9th ed.) Citation

Kang, Yeonah, et al. "Prognostic Value of Dynamic Contrast-Enhanced MRI-Derived Pharmacokinetic Variables in Glioblastoma Patients: Analysis of Contrast-Enhancing Lesions and Non-Enhancing T2 High-Signal Intensity Lesions." Korean Journal of Radiology, vol. 21, no. 6, 2020, pp. 707-716, https://doi.org/10.3348/kjr.2019.0629.